1 |
Kim BS, JarGal P, Min KS (2007): Biological activity of recombinant human thrombopoietin. J of Life Science 17:1497-1504.
과학기술학회마을
DOI
ScienceOn
|
2 |
Lee HG, Lee PY, Kee YJ, Kim SJ, Chung HK, Seo MK, Park JK, Min KS, Chang WK (2003): Effects of changes in glycosylation sites on secretion of recombinant human erythropoietin in cultured CHO cells. Korean J Animal Reprod 27:299-307.
과학기술학회마을
|
3 |
Broudy VC, Tait JF, Powell JS (1988): Recombinant human erythropoietin: Purification and analysis of carbohydrate linkage. Arch Biochem Biophys 265:329-336.
DOI
ScienceOn
|
4 |
Egrie JC, Dwer E, Browne JK, Hitz A, Lykos MA (2003): Darbepoitin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp Hematol 31:290-299.
DOI
ScienceOn
|
5 |
Saneyoshi T, Min KS, Ma XJ, Nambo Y, Hiyama T, Tanaka S, Shiota K (2001): Equine follicle-stimulating hormone: Molecular cloning of subunit and biological role of the asparagines-linked oligosaccharide at of subunit. Biol Reprod 65:1686-1690.
DOI
ScienceOn
|
6 |
Lacombe C, Da Silva JL, Bruneval P (1988): Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 81:620-623.
DOI
ScienceOn
|
7 |
Min KS, Shiota K, Saneyoshi T, Hirosawa M, Ogawa T (1997): Differential role of oligosaccharides in equine chorionic gonadotropin (eCG)/luteinizing hormone (LH) to express follicle stimulating hormone (FSH)- like and LH-like activities. J Reprod Dev 43: 177-179.
|
8 |
Min KS (2000): Biological functions of N- and O-linked oligisaccharides of equine chorionic gonadotropin and lutropin/choriogonadotropin receptor. Korean J Animal Reprod 24:357-364.
|
9 |
Park JJ, Lee HG, Nam IS, Park HJ, Kim MS, Chung YH, JarGal N, Kang HY, Lee PY, Park JG, Seong HH, Chang WK, Min KS (2005): Biological activity of recombinant human erythropoietin (EPO) in vivo and in vitro. Reprod Dev Biol 29:69-79.
과학기술학회마을
|
10 |
Min KS (2001): Biosynthesis of a biological active single chain equine chorionic gonadotropin. J Life Science 11:103-107.
|
11 |
Lai PH, Everett R, Wang FF, Arakawa T, Goldwasseer E (1986): Structural characterization of human erythropoietin. J Biol Chem 261:3116-3121.
|
12 |
Fares F, Ganem S, Hajouj T, Agai E (2007): Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin -subunit to the coding sequence of human erythropoietin. Endocrinology 148:5081-5087.
DOI
ScienceOn
|
13 |
Loo M, Beguin Y (1999): The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood 93:3286-3293.
|
14 |
Macdougall IC (2002): Optimizing the use of erythropoietic agents-pharmacokinetic and pharmacodynamic considerations. Nephrol Dial Transplant 17:66-70.
|
15 |
Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999): Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Mephol 10: 2392-2395.
|
16 |
Gross AW, Lodish HF (2006): Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem 281:2024-2032.
DOI
|
17 |
Benjamin LE, Franklin B (1999): Regulation of the erythropoietin gene. Blood 94:1864-1877.
|
18 |
JarGal N, Min KS (2009): Development and characterization of hyperglycosylated recombinant human erythropoietin (HGEPO). Reprod Dev Biol 33:77-83.
과학기술학회마을
|
19 |
Egrie JC, Strickand TW, Lane J, Aoki K, Cohen AM, Samlling R, Trail G, Lin FK, Browne JK, Hines DK (1986): Characterization and biological effects of recombinant human erythropoietin. Immunology 172: 213-244.
|
20 |
Ellioitt S, Lorenzini T, Chang D, Barzilay J, Delorme E (1997): Mapping of the active site of recombinant human erythropoietin. Blood 89:493-502.
|
21 |
Egrie JC, Brown JK (2002): Development and characterization of darbepoetin alfa. Oncology 16:13-22.
|
22 |
Bunn HF (2007): New agents that stimulate erythropoiesis. Blood 109:868-872.
|
23 |
Dalle B, Henri A, Rouyer-Fessard P, Bettan M, Scherman D, Beuzard Y, Payen E (2001): Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. Blood 15:3776-3782.
|
24 |
Egrie JC, Brown JK (2001): Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16:3-13.
|
25 |
Qiu H, Belanger A, Yoon HWP, Bunn HF (1998): Homodimerization restores biological activity to an inactive erythropoietin mutant. J Biol Chem 273: 11173-11176.
DOI
|
26 |
Wright NC, Farrell FX, Chang R (1996): Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-463.
DOI
ScienceOn
|
27 |
Sytkowski AJ, Lunn ED, Risinger MA, Davis KL (1999): An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties. J Biol Chem 274:24773-24778.
DOI
|
28 |
Takeuchi M, Inoue N, Strickand TW, Kobata M, Wada M, Shimizu R, Hoshi S, Kozutsumi H, Takasaki S, Kokbata A (1989): Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc Natl Acad Sci USA 86:7819-7822.
DOI
ScienceOn
|
29 |
Wolf RF, Peng J, Friese P, Gilmore LS, Burstein SA, Dale GL (1997a): Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 78:1505-1509.
|
30 |
Wolf RF, Gilmore LS, Friese P, Downs T Burstein SA, Dale GL (1997b): Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model. Thromb Haemost 77:1020-1024.
|
31 |
Sakaki H, Bothner B, Dell A, Fukuda M (1987): Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Bio Chem 27:24773-24778.
|
32 |
Min KS, Hiyama T, Seong HH, Hattori S, Tanaka S, Shiota K (2004): Biological activities of tethered chorionic gonadotropin (eCG) and its deglycosylated mutants. J Reprod Dev 50:297-304.
DOI
ScienceOn
|
33 |
Park JJ, JarGal N, Yoon JT, Min KS (2010): -subunit 94-96 residues of tethered recombinant equine chorionic gonadotropin are important sites for luteinizing hormone and follicle stimulating hormone like activities. Reprod Dev Biol 34:33-40.
과학기술학회마을
|
34 |
Min KS, Hattori N, Aikawa K, Shiota K, Ogawa T (1996): Site-directed mutagenesis of recombinant equine chorionic gonadotropin/luteinizing hormone: differential role of oligosaccharides in luteinizing hormone and follicle-stimulating hormone-like activities. Endocrine J 43:585-593.
DOI
ScienceOn
|